MC
ODT

Menta Capital’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Menta Capital’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$304K Sell
8,283
-1,910
-19% -$45.8K 0.13% 299
2019
Q1 		$225K Sell
10,193
-3,121
-23% -$54.6K 0.1% 356
2018
Q4 		$187K Buy
+13,314
New +$207K 0.07% 441

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Menta Capital's ODT Position: Q2 2019 in Review

Menta Capital reduced its Odonate Therapeutics, Inc. Common Stock (ODT) stake by 19% in Q2 2019, selling an estimated $45.8K and leaving 8,283 shares worth $304K. The position accounts for 0.13% of the portfolio, ranked #299.

Menta Capital first reported a position in ODT in Q4 2018 and has held it in 3 quarters since. 77 funds tracked by Wall St. Rank hold ODT as of Q2 2019.

  • Menta Capital held 8,283 shares of Odonate Therapeutics, Inc. Common Stock worth $304K as of Q2 2019.
  • Menta Capital sold 1,910 Odonate Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $45.8K.
  • Odonate Therapeutics, Inc. Common Stock made up 0.13% of Menta Capital's portfolio in Q2 2019, its #299 holding.
  • Menta Capital first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2018 and has held it in 3 quarters since.
  • 77 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.